Drug industry evading drug equivalency test works

The drug industry paid more interests in the bio-equivalent tests than the works on drug equivalency proof for general drugs, which ultimately resulted in number of generic drugs being so declined that the generic drug dispensing enforced by the provisions would encounter with many hurdles.

The KFDA encouraged earlier in July for 48 items of generic drugs supplied from 32 companies to conduc...